MYX mayne pharma group limited

Ann: 2022 Half Year Investor Presentation, page-111

  1. 11,740 Posts.
    lightbulb Created with Sketch. 1629
    Well - share price keeps going down, revenue keeps going down, margins keep contracting and shorters play pass the parcel. They had years to build a business and failing on every turn... their ebitda/debt ratio is precarious and if E4 fails the concerns are more than justified. But as a contrarian high risk investment - sure, why not. In terms as a well managed business just lol.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.010(0.20%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.13 $5.15 $5.08 $445.2K 87.01K

Buyers (Bids)

No. Vol. Price($)
1 810 $5.08
 

Sellers (Offers)

Price($) Vol. No.
$5.15 2033 2
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.